Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1993 Jun;56(6):615–621. doi: 10.1136/jnnp.56.6.615

Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci.

I Savic 1, M Ingvar 1, S Stone-Elander 1
PMCID: PMC489609  PMID: 8509773

Abstract

Recent PET results indicate that the benzodiazepine (BZ) receptor density measured with the BZ receptor antagonist [11C]flumazenil is reduced in human epileptic foci. The present study examines the applicability of this finding in the presurgical investigation of patients with intractable partial epilepsy. In eight patients, the PET measurements were performed after injection of the BZ receptor antagonist [11C]flumazenil and [2-18F]2-deoxy-2-fluoro-D-glucose ([18F]FDG)--a tracer for measurements of the rate of regional glucose metabolism. The focus localising ability of the two PET tracers was examined using extra--and intracranial EEG recordings as reference. The focus was first determined visually on the PET images obtained after a bolus injection of each of the PET tracers. Its anatomical localisation and spatial delimitation was then evaluated for each patient with a computerised anatomical brain atlas. [11C]flumazenil was found to be a more sensitive and accurate focus localiser than [18F]FDG. This observation was valid both for quantified and non-quantified images. In the preoperative diagnosis of epileptic foci, the PET measurements of BZ receptors may be a suitable and, in some cases, superior method to the generally used "[18F]FDG-PET" method.

Full text

PDF
615

Images in this article

617Image
on p.617

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackermann R. F., Finch D. M., Babb T. L., Engel J., Jr Increased glucose metabolism during long-duration recurrent inhibition of hippocampal pyramidal cells. J Neurosci. 1984 Jan;4(1):251–264. doi: 10.1523/JNEUROSCI.04-01-00251.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergström M., Boëthius J., Eriksson L., Greitz T., Ribbe T., Widén L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr. 1981 Feb;5(1):136–141. doi: 10.1097/00004728-198102000-00027. [DOI] [PubMed] [Google Scholar]
  3. Blomqvist G., Pauli S., Farde L., Eriksson L., Persson A., Halldin C. Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements. Eur J Nucl Med. 1990;16(4-6):257–265. doi: 10.1007/BF00842777. [DOI] [PubMed] [Google Scholar]
  4. Engel J., Jr, Brown W. J., Kuhl D. E., Phelps M. E., Mazziotta J. C., Crandall P. H. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol. 1982 Dec;12(6):518–528. doi: 10.1002/ana.410120604. [DOI] [PubMed] [Google Scholar]
  5. Engel J., Jr, Henry T. R., Risinger M. W., Mazziotta J. C., Sutherling W. W., Levesque M. F., Phelps M. E. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology. 1990 Nov;40(11):1670–1677. doi: 10.1212/wnl.40.11.1670. [DOI] [PubMed] [Google Scholar]
  6. Greitz T., Bohm C., Holte S., Eriksson L. A computerized brain atlas: construction, anatomical content, and some applications. J Comput Assist Tomogr. 1991 Jan-Feb;15(1):26–38. [PubMed] [Google Scholar]
  7. Halldin C., Stone-Elander S., Thorell J. O., Persson A., Sedvall G. 11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors. Int J Rad Appl Instrum A. 1988;39(9):993–997. doi: 10.1016/0883-2889(88)90044-5. [DOI] [PubMed] [Google Scholar]
  8. Henry T. R., Mazziotta J. C., Engel J., Jr, Christenson P. D., Zhang J. X., Phelps M. E., Kuhl D. E. Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cereb Blood Flow Metab. 1990 Sep;10(5):748–757. doi: 10.1038/jcbfm.1990.128. [DOI] [PubMed] [Google Scholar]
  9. Johnson E. W., de Lanerolle N. C., Kim J. H., Sundaresan S., Spencer D. D., Mattson R. H., Zoghbi S. S., Baldwin R. M., Hoffer P. B., Seibyl J. P. "Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology. 1992 Apr;42(4):811–815. doi: 10.1212/wnl.42.4.811. [DOI] [PubMed] [Google Scholar]
  10. Koeppe R. A., Holthoff V. A., Frey K. A., Kilbourn M. R., Kuhl D. E. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab. 1991 Sep;11(5):735–744. doi: 10.1038/jcbfm.1991.130. [DOI] [PubMed] [Google Scholar]
  11. Litton J., Bergström M., Eriksson L., Bohm C., Blomqvist G., Kesselberg M. Performance study of the PC-384 positron camera system for emission tomography of the brain. J Comput Assist Tomogr. 1984 Feb;8(1):74–87. doi: 10.1097/00004728-198402000-00016. [DOI] [PubMed] [Google Scholar]
  12. Miles R. Synaptic excitation of inhibitory cells by single CA3 hippocampal pyramidal cells of the guinea-pig in vitro. J Physiol. 1990 Sep;428:61–77. doi: 10.1113/jphysiol.1990.sp018200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Overstreet D. H., Yamamura H. I. Receptor alterations and drug tolerance. Life Sci. 1979 Nov 26;25(22):1865–1877. doi: 10.1016/0024-3205(79)90607-6. [DOI] [PubMed] [Google Scholar]
  14. Persson A., Ehrin E., Eriksson L., Farde L., Hedström C. G., Litton J. E., Mindus P., Sedvall G. Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res. 1985;19(4):609–622. doi: 10.1016/0022-3956(85)90080-9. [DOI] [PubMed] [Google Scholar]
  15. Reivich M., Alavi A., Wolf A., Fowler J., Russell J., Arnett C., MacGregor R. R., Shiue C. Y., Atkins H., Anand A. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab. 1985 Jun;5(2):179–192. doi: 10.1038/jcbfm.1985.24. [DOI] [PubMed] [Google Scholar]
  16. Sackellares J. C., Siegel G. J., Abou-Khalil B. W., Hood T. W., Gilman S., McKeever P. E., Hichwa R. D., Hutchins G. D. Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology. 1990 Sep;40(9):1420–1426. doi: 10.1212/wnl.40.9.1420. [DOI] [PubMed] [Google Scholar]
  17. Savic I., Persson A., Roland P., Pauli S., Sedvall G., Widén L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet. 1988 Oct 15;2(8616):863–866. doi: 10.1016/s0140-6736(88)92468-3. [DOI] [PubMed] [Google Scholar]
  18. Savic I., Widen L., Thorell J. O., Blomqvist G., Ericson K., Roland P. Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy. Epilepsia. 1990 Nov-Dec;31(6):724–730. doi: 10.1111/j.1528-1157.1990.tb05513.x. [DOI] [PubMed] [Google Scholar]
  19. Savic I., Widén L., Stone-Elander S. Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet. 1991 Jan 19;337(8734):133–137. doi: 10.1016/0140-6736(91)90799-u. [DOI] [PubMed] [Google Scholar]
  20. Seitz R. J., Bohm C., Greitz T., Roland P. E., Eriksson L., Blomqvist G., Rosenqvist G., Nordell B. Accuracy and precision of the computerized brain atlas programme for localization and quantification in positron emission tomography. J Cereb Blood Flow Metab. 1990 Jul;10(4):443–457. doi: 10.1038/jcbfm.1990.87. [DOI] [PubMed] [Google Scholar]
  21. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettigrew K. D., Sakurada O., Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977 May;28(5):897–916. doi: 10.1111/j.1471-4159.1977.tb10649.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES